Toll-like receptor 7 deficiency mitigates hyperoxia-induced acute lung injury in mice - 28/08/20
páginas | 6 |
Iconografías | 5 |
Vídeos | 0 |
Otros | 0 |
Graphical abstract |
Highlights |
• | TLR 7 plays a pivotal role in hyperoxia-induced acute lung injury. |
• | TLR 7 mediates soluble epoxide hydrolase upregulation. |
• | TLR 7 mediates AP-1 and NF-κB activation in hyperoxic acute lung injury. |
Abstract |
Introduction |
Toll-like receptor (TLR) 7 is an important mediator in inflammation. However, its role in hyperoxia-induced acute lung injury (HALI) remains to be elucidated.
Methods |
C57BL/6 wild-type and C57BL/6 background TLR 7 deficiency mice were exposed to hyperoxia to stimulate HALI in airtight cages. Animals were sacrificed at 72 h post hyperoxia or room air exposure. Lung injury indicators were measured. Moreover, soluble epoxide hydrolase (sEH) activity was detected by a 14, 15-EET/DHET ELISA kit. Activation of activator protein (AP)-1 and nuclear factor kappa-B (NF-κB) was detected with enzyme linked immunosorbent assay kits.
Results |
Our data revealed that pulmonary histological assay and wet to dry weight ratio, myeloperoxidase and malondialdehyde activity were reduced in TLR 7 deficiency mice compared with wild-type mice. Moreover, hyperoxia–caused elevation of sEH activity was reduced in TLR 7 deficiency mice. Transcription factors AP-1 activation was significantly inhibited in TLR 7 deficiency mice compared with wild-type mice. Similarly, the activation of NF-κB was reduced in TLR 7 deficiency mice. Tumor necrosis factor-α and interleukin-1β, potent proinflammatory cytokines, were reduced in TLR 7 deficiency mice.
Conclusion |
TLR 7 deficiency is associated with inhibition of inflammation in HALI in mice.
El texto completo de este artículo está disponible en PDF.Keywords : Inflammation, Acute lung injury, Hyperoxia, NF-κB
Esquema
Vol 129
Artículo 110345- septembre 2020 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?